Better Biotechnology ETF: First Trust FBT vs. VanEck BBH
The First Trust NYSE Arca Biotechnology Index Fund (NYSEMKT:FBT) offers broader exposure and higher recent returns, while the VanEck Biotech ETF (NASDAQ:BBH) provides a lower-cost, highly concentrated portfolio of industry giants.
Biotechnology is a high-stakes corner of the healthcare market, characterized by immense research costs and binary regulatory outcomes. With $2.9 billion in assets under management (AUM), the First Trust fund is significantly larger than the VanEck fund. Both ETFs provide diversified access to companies that may be too risky to own individually.
Beta measures price volatility relative to the S&P 500; beta is calculated from monthly returns over the available fund history (up to five years). The 1-year return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield.
Source: www.fool.com — article syndicated from the publisher’s feed; all rights remain with the original publisher.